BoardVitals - Cardiovascular
MAY 15, 2022
The Cardiovascular Disease Maintenance of Certification Exam can be difficult, with a pass rate in 2021 of 88%. In early 2022, the ABIM updated its fee structure to help physicians pay less over time to maintain their certifications. What are some things you need to know before you sit for the exam? How much does the exam cost?
BoardVitals - Cardiovascular
JULY 26, 2022
This certification is known to be one of the harder ones, with a pass rate of 88% in 2021 , so don’t procrastinate studying. Heart Failure and Cardiomyopathy 19% Valvular Disease 15% Pericardial Disease 3% Congenital Heart Disease 3% Vascular Diseases 5% Systemic Hypertension and Hypotension 8.5%
Circulation: Heart Failure
NOVEMBER 11, 2024
Background:Mavacamten is the only cardiac myosin inhibitor approved by the US FDA for treatment of symptomatic New York Heart Association class II-III obstructive hypertrophic cardiomyopathy (HCM) patients. We report results from the mavacamten REMS database (28-Apr-2022 to 27-Feb-2024).Methods:Data were women; 64.6%
Circulation
NOVEMBER 11, 2024
The mortality rate of alcohol-related cardiomyopathy using ICD code I42.6 Alcoholic cardiomyopathy) was studied from 2001-2020. 100,000 deaths.Conclusions:The mortality trends associated with alcohol-related cardiomyopathy have not changed significantly over the past two decades. 100,000 deaths in four U.S
Journal of the American Heart Association
MARCH 25, 2025
BackgroundDedicated hypertrophic cardiomyopathy (HCM) center cohorts have reported reductions in HCMrelated deaths, likely due to the introduction of contemporary treatments. Journal of the American Heart Association, Ahead of Print. HCMrelated mortality trends were compared with nonHCM cardiovascular deaths and allcause deaths.
Expert insights. Personalized for you.
52 
Let's personalize your content